RE:
http://en.trend.az/regions/iran/2108864.htmlSome good points.....
The study , per the web page description, has several problems which make it rather weak:
1. Only 65 patients finished the study. ( very small sample)
2. Duration of the study was okay ( 1 year, so we do not know what will happen after a year)
3. There is no mentioning about the type of the study, example; was it " cohort" ? " clinical trial" ? " double blinded" ? because if a study is not " Double-blinded clinical trial " or " large sample Cohort" is not usually a valuble study.
4. There is no table or graph that explain the side effects, reasons that patients dropped off , patients' age group, patients' sex, and etc... not enough data provided.
5. The treatment is only effective in mild cases, not in moderate or sever cases of MS!
She will continue looking into this by contacting of my old classmates (medical) and family in Iran
This article was from the news. Do not expect any graph or scientific desription of the study in such forum. Do you think Washington Post would cover the story in that details?:)
The herbal substance is taken with current MS drugs and results have been observed this way. Most of the patients showed relative improvements. The sample is smal, just as it is always in phase 1/2. No major sideeffects have been observed. The study is going on.